Caricamento...
Combination Therapies and Drug Delivery Platforms in Combating Pancreatic Cancer
Pancreatic ductal adenocarcinoma (PDAC), the fourth leading cause of cancer-related death in the United States, is highly aggressive and resistant to both chemo- and radiotherapy. It remains one of the most difficult-to-treat cancers, not only due to its unique pathobiological features such as strom...
Salvato in:
| Pubblicato in: | J Pharmacol Exp Ther |
|---|---|
| Autori principali: | , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
The American Society for Pharmacology and Experimental Therapeutics
2019
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6806650/ https://ncbi.nlm.nih.gov/pubmed/30796131 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1124/jpet.118.255786 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|